Search

Search any products, services and so on here.

About 4390 result(s)

Global Huperzine A Drug Market Research Report 2025

  • Apr 16, 25
  • ID: 198255
  • Pages: 85
  • Figures: 80
  • Views: 0
  • From $2,900

The global market for Huperzine A Drug was valued at US$ 36.4 million in the year 2024 and is projected to reach a revised size of US$ 79.4 million by 2031, growing at a CAGR of 12.3% during the forecast period. Huperzine A is a new type of effective monomer of lycopodiella alkaloids isolated by Chinese scientists from the folk herb Huperzine in 1982. It is essentially a reversible acetylcholinest...


Global Immune Checkpoint Blockers Market Research Report 2025

  • Apr 16, 25
  • ID: 18399
  • Pages: 86
  • Figures: 80
  • Views: 5
  • From $2,900

The global market for Immune Checkpoint Blockers was valued at US$ 24390 million in the year 2024 and is projected to reach a revised size of US$ 72040 million by 2031, growing at a CAGR of 17.0% during the forecast period. Immune Checkpoint Blockers are a class of drugs that enhance the immune system's ability to target tumors by inhibiting the action of negative regulatory molecules within the i...


Global Recombinant Human Serum Albumin Market Research Report 2025

  • Apr 16, 25
  • ID: 117585
  • Pages: 80
  • Figures: 87
  • Views: 4
  • From $2,900

The global market for Recombinant Human Serum Albumin was valued at US$ 85.1 million in the year 2024 and is projected to reach a revised size of US$ 137 million by 2031, growing at a CAGR of 7.2% during the forecast period. Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating se...


Global Sevoflurane (Sevoflurane Source) Market Research Report 2025

  • Apr 16, 25
  • ID: 196016
  • Pages: 84
  • Figures: 84
  • Views: 0
  • From $2,900

The global market for Sevoflurane (Sevoflurane Source) was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period. Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offs...


Global Iloprost Drugs Market Research Report 2025

  • Apr 16, 25
  • ID: 195932
  • Pages: 61
  • Figures: 61
  • Views: 0
  • From $2,900

The global market for Iloprost Drugs was valued at US$ 87.2 million in the year 2024 and is projected to reach a revised size of US$ 78 million by 2031, growing at a CAGR of -1.6% during the forecast period. Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud"s phenomenon and other diseases in which the blood vessels are constricted and blood can"t flow to...


Global Treprostinil Drugs Market Research Report 2025

  • Apr 16, 25
  • ID: 195930
  • Pages: 74
  • Figures: 67
  • Views: 0
  • From $2,900

The global market for Treprostinil Drugs was valued at US$ 1331 million in the year 2024 and is projected to reach a revised size of US$ 1665 million by 2031, growing at a CAGR of 3.3% during the forecast period. Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92%...


Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2025

  • Apr 16, 25
  • ID: 195874
  • Pages: 103
  • Figures: 103
  • Views: 0
  • From $2,900

The global market for Swine Reproductive and Respiratory Syndrome Vaccine was valued at US$ 515 million in the year 2024 and is projected to reach a revised size of US$ 1006 million by 2031, growing at a CAGR of 10.2% during the forecast period. Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory sympt...


Global Heart Failure Drugs Market Research Report 2025

  • Apr 16, 25
  • ID: 195846
  • Pages: 88
  • Figures: 95
  • Views: 0
  • From $2,900

The global market for Heart Failure Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Heart failure occurs when your heart muscle doesn"t pump blood as well as it should. The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption pl...


Global Panax Quinquefolius Market Research Report 2025

  • Apr 16, 25
  • ID: 195774
  • Pages: 81
  • Figures: 82
  • Views: 0
  • From $2,900

The global market for Panax Quinquefolius was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 4427 million by 2031, growing at a CAGR of 16.0% during the forecast period. Panax Quinquefolius (American Ginseng) is a herbaceous perennial plant in the ivy family, commonly used as an herb in traditional medicine, including traditional Chinese Medicine. It is...


Global Sarcopenia Treatments Market Research Report 2025

  • Apr 16, 25
  • ID: 195771
  • Pages: 87
  • Figures: 85
  • Views: 0
  • From $2,900

The global market for Sarcopenia Treatments was valued at US$ 3021 million in the year 2024 and is projected to reach a revised size of US$ 4120 million by 2031, growing at a CAGR of 4.6% during the forecast period. Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function. China is the largest consumption region of Sarcopenia Treatment, with market share n...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232